Association of cytokine polymorphisms with subclinical progressive chronic allograft nephropathy in Japanese renal transplant recipients: Preliminary study

International Journal of Urology

Volumn 14, Issue 11, 2007, Pages 990-994

  Satoh, Shigeru ^a   Saito, Mitsuru ^a   Inoue, Kazuyuki ^a   Miura, Masatomo ^a   Komatsuda, Atsushi ^a   Habuchi, Tomonori ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

CAN; Cytokine; IL 2 T 330G; IL 4 C 590T; Polymorphism

Indexed keywords

BASILIXIMAB; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; AGE; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; DRUG DOSE REDUCTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GRAFT RECIPIENT; GRAFT REJECTION; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; JAPANESE; KIDNEY GRAFT; MALE; ORGAN DONOR; PLASMAPHERESIS; PRIORITY JOURNAL; RISK FACTOR; UNIVARIATE ANALYSIS;

CHRONIC DISEASE; CREATININE; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; INTERLEUKIN-4; JAPAN; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TACROLIMUS;

EID: 35448944055     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01886.x     Document Type: Article

References (32)

1. Schwarz A, Mengel M, Gwinner W et al. Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int. 2005 67 : 341 8.
2. Ortiz F, Paavonen T, Tornroth T et al. Predictors of renal allograft histologic damage progression. J. Am. Soc. Nephrol. 2005 16 : 817 24.
3. Oppenheimer F, Aljama P, Asensio Peinado C, Bustamante Bustamante J, Crespo Albiach JF, Guirado Perich L. The impact of donor age on the results of renal transplantation. Nephrol. Dial. Transplant. 2004 19 (Suppl 3 iii, 1 5.
4. Scolari MP, Cappuccilli ML, Lanci N et al. Predictive factors in chronic allograft nephropathy. Transplant. Proc. 2005 37 : 2482 4.
5. Micozkadioglu H, Ozdemir FN, Sezer S, Arat Z, Haberal M. Weight gain after living-related renal transplantation affects long-term graft function. Transplant. Proc. 2005 37 : 1029 32.
6. Arias M, Fernandez-Fresnedo G, Rodrigo E, Ruiz JC, Gonzalez-Cotorruelo J, Gomez-Alamillo C. Non-immunologic intervention in chronic allograft nephropathy. Kidney Int. Suppl. 2005 99 : S118 23.
7. de Vries AP, Bakker SJ, van Son WJ et al. Insulin resistance as putative cause of chronic renal transplant dysfunction. Am. J. Kidney Dis. 2003 41 : 859 67.
8. Bakker RC, Hollander AA, Mallat MJ, Bruijn JA, Paul LC, de Fijter JW. Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy. Kidney Int. 2003 64 : 1027 34.
9. Cox ED, Hoffmann SC, DiMercurio BS et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 2001 72 : 720 6.
10. Melk A, Henne T, Kollmar T et al. Cytokine single nucleotide polymorphisms and intrarenal gene expression in chronic allograft nephropathy in children. Kidney Int. 2003 64 : 314 20.
11. Viklicky O, Hubacek JA, Kvasnicka J et al. Association of methylenetetrahydrofolate reductase T677 allele with early development of chronic allograft nephropathy. Clin. Biochem. 2004 37 : 919 24.
12. Pawlik A, Domanski L, Rozanski J et al. The cytokine gene polymorphisms in patients with chronic kidney graft rejection. Transpl. Immunol. 2005 14 : 49 52.
13. Muller-Steinhardt M, Fricke L, Muller B, Ebel B, Kirchner H, Hartel C. Cooperative influence of the interleukin-6 promoter polymorphisms -597-572 and - 174 on long-term kidney allograft survival. Am. J. Transplant. 2004 4 : 402 6.
14. Smolnikova MV, Konenkov VI. Association of IL2, TNFA, IL4 and IL10 promoter gene polymorphisms with the rate of progression of the HIV infection. Russ. J. Immunol. 2002 7 : 349 56.
15. Momiyama Y, Ohmori R, Nagano M et al. Polymorphism of the 3′-untranslated region of interleukin-12 p40 gene is not associated with the presence or severity of coronary artery disease. Circ. J. 2005 69 : 793 7.
16. Tinckam K, Rush D, Hutchinson I et al. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation 2005 79 : 836 41.
17. Khalil MS, EI Nahas AM, Blakemore AI. Transforming growth factor-beta 1 SNPs: Genetic and phenotypic correlations in progressive kidney insufficiency. Nephron Exp. Nephrol. 2005 101 : e31 41.
18. Yuan FF, Watson N, Sullivan JS et al. Association of Fc gamma receptor IIA polymorphisms with acute renal-allograft rejection. Transplantation 2004 78 : 766 9.
19. Quiroga I, McShane P, Koo DD et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol. Dial. Transplant. 2006 21 : 1689 96.
20. Helantera I, Koskinen P, Finne P et al. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival. Transpl. Int. 2006 19 : 893 900.
21. Solez K, Colvin RB, Racusen LC et al. Banff ′05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am. J. Transplant. 2007 7 : 518 26.
22. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N. Engl. J. Med. 2003 349 : 2326 33.
23. Seron D, Moreso F, Fulladosa X, Hueso M, Carrera M, Grinyo JM. Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int. 2002 61 : 727 33.
24. Hoffmann SC, Stanley EM, Darrin Cox E et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28- stimulated peripheral blood lymphocytes. Transplantation 2001 72 : 1444 50.
25. Pawlik A, Kurzawski M, Florczak M, Gawronska Szklarz B, Herczynska M. IL1 beta+3953 exon 5 and IL-2-330 promoter polymorphisms in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 2005 23 : 159 64.
26. MacMillan ML, Radloff GA, Kiffmeyer WR, DeFor TE, Weisdorf DJ, Davies SM. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation. Transplantation 2003 76 : 1758 62.
27. Matesanz F, Fedetz M, Leyva L, Delgado C, Fernandez O, Alcina A. Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression. J. Neuroimmunol. 2004 148 : 212 17.
28. Pawlik A, Domanski L, Rozanski J et al. IL-2 and TNF-α promoter polymorphisms in patients with acute kidney graft rejection. Transplant. Proc. 2005 37 : 2041 3.
29. Hamar P, Szabo A, Muller V, Heemann U. The involvement of activated T cells and growth-factor production in the early and late phase of chronic kidney allograft nephropathy in rats. Transpl. Int. 2002 15 : 446 54.
30. Poole KL, Gibbs PJ, Evans PR, Sadek SA, Howell WM. Influence of patient and donor cytokine genotypes on renal allograft rejection: Evidence from a single center study. Transpl. Immunol. 2001 8 : 259 65.
31. Lee H, Clark B, Gooi HC, Stoves J, Newstead CG. Influence of recipient and donor IL-1 alpha, IL-4, and TNF alpha genotypes on the incidence of acute renal allograft rejection. J. Clin. Pathol. 2004 57 : 101 3.
32. Cartwright NH, Keen LJ, Demaine AG et al. A Study of cytokine gene polymorphisms and protein secretion in renal transplantation. Transpl. Immunol. 2001 8 : 237 44.